Photo of: Charles Cooney

Dr. Charles L. Cooney

View Title...

Charles's profile was created using:
Sort By:

1-10 of 196 online sources for Charles Cooney

  • View Online Source
    www.sec.gov/Archives/edgar/data/732485/0001047469-09-00 - [Cached Version]
    Published on: 4/13/2009    Last Visited: 4/14/2009  

    Douglas A. Berthiaume, Gail K. Boudreaux, Robert J. Carpenter, Charles L. Cooney, Victor J. Dzau, Senator Connie Mack III, Richard F. Syron and Henri A. Termeer were recommended for re-election to the board by our nominating and corporate governance committee and selected for nomination by the board of directors.
    ...
    Charles L. Cooney, Ph.D., director since 1983

    Dr. Cooney, 64, is the Robert T. Haslam (1911) Professor of Chemical and Biochemical Engineering and Faculty Director, Deshpande Center for Technological Innovation at Massachusetts Institute of Technology. Dr. Cooney joined the MIT faculty as an Assistant Professor in 1970 and became a Professor in 1982. Dr. Cooney is a director of Polypore International, Inc. and a principal of BioInformation Associates, Inc., a consulting company.

  • View Online Source
    www.healthtech.com/conference/00pgd/index.htm - [Cached Version]
    Published on: 6/26/1999    Last Visited: 8/11/2000  

    Dr. Charles L. Cooney, Massachusetts Institute of Technology
    ...
    Dr. Charles L. Cooney, Professor of Chemical and Biochemical Engineering, Department of Chemical Engineering, Massachusetts Institute of Technology

    Phage Display in Antibacterial Drug DiscoveryAntimicrobial PeptidesZinc Finger Proteins
    ...
    Dr. Charles L. Cooney, Professor of Chemical and Biochemical Engineering, Department of Chemical Engineering, Massachusetts Institute of TechnologyPhage display enables the creation of large libraries of peptide epitopes presented on a variety of structural motifs.With this convenient access to biodiversity one can screen for physical, chemical, and biological interactions with the peptides.The application of this core technology touches all aspects of drug discovery and development from early-stage target validation to implementation of clinical trials.

  • View Online Source
    masshightech.bizjournals.com/masshightech/stories/2007/ - [Cached Version]
    Published on: 11/19/2007    Last Visited: 12/1/2007  

    The initiative will be organized through the Deshpande Center within MIT's School of Engineering, and will be headed by professor Charles L. Cooney.

  • View Online Source
    news.my-medicare.com/jan-07/states-push-for-generics.ht - [Cached Version]
    Published on: 3/30/2007    Last Visited: 3/30/2007  

    "The more complex the molecule, the more complex the risk," said Dr. Charles L. Cooney, a professor of biochemical engineering at the Massachusetts Institute of Technology, who said that the process would have to be tailored to each specific drug.

    But he argues that insulin is a relatively simple molecule that has been produced by several manufacturers.

    "I think that most people accept that fact, that some of the simpler molecules - insulin, human growth hormone - may require less testing to assure safety and efficacy," Dr. Cooney said.

    The nation's insulin market is currently dominated by three companies: the Danish manufacturer Novo Nordisk, the American drug maker Eli Lilly & Company and the French company Sanofi-Aventis.

  • View Online Source
    www.drugdisc.com/cod/oinfo_lower.asp?PRODUCT_COD_ID=USC - [Cached Version]
    Published on: 9/27/2003    Last Visited: 11/6/2004  

    Charles Cooney, Ph.D., Professor, Chemical and Biochemical Engineering, Massachusetts Institute of Technology, USA
    ...
    Keynote presentations from: Dr. R.A. Mashelkar, Director General, CSIR, India; Charles Cooney, Ph.D., Professor, Massachusetts Institute of Technology, USA; Lars Walan, VP, Global Drug Development, Emerging Markets, AstraZeneca, Sweden
    ...
    Charles Cooney, Professor, MIT

  • View Online Source
    www.massdevelopment.com/press/02092004-01.aspx - [Cached Version]
    Published on: 2/9/2004    Last Visited: 3/6/2007  

    To quote Dr. Charlie Cooney of MIT, "tech transfer is a contact sport," and this is especially true of first products and first technologies.

  • View Online Source
    www.recovery10.com/recovery10.nsf/Contacts?OpenForm&Aut - [Cached Version]
    Published on: 7/17/2000    Last Visited: 8/6/2001  

    Charles L. CooneyMIT

  • View Online Source
    indiaedunews.net/International/Montek_Singh_to_deliver_ - [Cached Version]
    Last Visited: 9/2/2009  

    The initiative is led by Professor Abhijit Banerjee and Professor Charles Cooney, who launched the Forum as a way to stimulate interest in and knowledge about India, and to discuss and debate the most pressing issues facing India today.

  • View Online Source
    www.biocon.com/biocon_invrelation_basic_data.asp - [Cached Version]
    Published on: 12/31/2003    Last Visited: 3/26/2007  

    Prof. Charles Cooney, Director

  • View Online Source
    www.upi.com/ConsumerHealthDaily/robotic_arm_aids_stroke - [Cached Version]
    Published on: 3/23/2007    Last Visited: 3/24/2007  

    On average, 23 percent of arm function improved after using the brace -- which is portable and lightweight and slides onto the arm, according to Charles Cooney, faculty director of the Deshpande Center at MIT.

    In addition, the arm-muscle tightness typical of stroke victims was greatly reduced.

Page:  1 2 3 4 5 Next

Wrong Person?

Try these instead
Related searches
More...

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-09-28_RC001.1 OM11